Interestingly, Smyd-2 has been shown to promote tumor growth in Ovarian Clear-Cell Carcinoma (OCCC) and Colorectal Cancer (CRC) by inhibiting TNF-induced apoptosis [71,72]. This evidence concerns the gene TNF and colorectal cancer.